Drug Trial Radar · NCT07553637
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
178
Planned (sponsor's estimate)
Start
May 20, 2026
Primary completion
Nov 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Alto NeuroscienceIndustry
- Sponsor type
- Industry
- First posted
- Apr 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Conditions
- Treatment-resistant Depression (TRD)
Interventions
ALTO-207Drug
ALTO-207 BID
PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the MADRS total scoreTime frame: Change from baseline up to 8 weeks
Locations
63 sites in 2 countries. Site status is shown where the registry gives one.
Site 7173
Dothan, Alabama · Recruiting
Site 7000
Phoenix, Arizona · Recruiting
Site 7153
Chino, California · Recruiting
Site 7195
La Jolla, California · Not yet recruiting
Site 7069
Los Angeles, California · Recruiting
Site 7156
Oakland, California · Recruiting
Site 7082
Oceanside, California · Recruiting
Site 7159
Palo Alto, California · Not yet recruiting
Site 7016
Sacramento, California · Recruiting
Site 7144
San Diego, California · Recruiting
Site 7120
San Jose, California · Recruiting
Site 7171
Valley Village, California · Recruiting
Site 7200
Wilton, Connecticut · Not yet recruiting
Site 7152
Saint Augustine, Florida · Recruiting
Site 7148
Albany, Georgia · Recruiting
Site 7146
Marietta, Georgia · Recruiting
Site 7141
Savannah, Georgia · Recruiting
Site 7064
Snellville, Georgia · Recruiting
Site 7192
Naperville, Illinois · Recruiting
Site 7169
Indianapolis, Indiana · Recruiting
Site 7151
Annapolis, Maryland · Withdrawn
Site 7185
Baltimore, Maryland · Not yet recruiting
Site 7054
Pikesville, Maryland · Recruiting
Site 7180
Rockville, Maryland · Recruiting
Site 7166
Worcester, Massachusetts · Recruiting
Site 7155
Ann Arbor, Michigan · Recruiting
Site 7154
Bloomfield Hills, Michigan · Recruiting
Site 7178
Grand Rapids, Michigan · Not yet recruiting
Site 7189
St Louis, Missouri · Recruiting
Site 7066
Toms River, New Jersey · Recruiting
Site 7170
Amherst, New York · Recruiting
Site 7055
Cedarhurst, New York · Recruiting
Site 7162
Lewiston, New York · Recruiting
Site 7157
Syracuse, New York · Recruiting
Site 7127
Cary, North Carolina · Recruiting
Site 7143
Charlotte, North Carolina · Recruiting
Site 7029
Cincinnati, Ohio · Recruiting
Site 7194
Dayton, Ohio · Not yet recruiting
Site 7158
Garfield Heights, Ohio · Recruiting
Site 7172
East Providence, Rhode Island · Recruiting
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.